Clinical trial Recruiting at 2 sites Phase 2 Interventional Ages 18 and up

Comparing two pain management methods after knee surgery

Official title: Yale Steroid Enhanced Versus Exparel Nerveblock TKA Randomized Controlled Trial (RCT) Study

Run by Yale University · NCT05279092 · Data updated 2026-11-12

This study is testing two different pain management methods after knee surgery to see which one helps patients feel better and recover more effectively.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorYale University
Academic / other
Locations2 sites (New Haven, Connecticut and 1 other locations)
StatusRecruiting
StartedSeptember 8, 2022
Main results expectedSeptember 2027
Study endsMarch 2028
Registry record updatedJuly 23, 2026
Trial IDNCT05279092 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients scheduled for elective, primary, unilateral total knee arthroplasty with ASA status I, II, or III.

Probably not a fit

Patients with conditions such as coagulopathy, uncontrolled diabetes, or those on opioids may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This phase 2, double-blinded, randomized clinical trial aims to evaluate the effectiveness of a combination of Dexamethasone sodium phosphate and Methylprednisolone acetate with plain bupivacaine against Liposomal Bupivacaine with plain bupivacaine for pain control in patients undergoing unilateral total knee arthroplasty. The study will enroll 250 patients at Yale New Haven Hospital, who will be randomly assigned to receive one of the two treatments. Additionally, the trial will assess the quality of postoperative recovery and surgical outcomes associated with each pain management approach.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management and recovery for patients undergoing knee replacement surgery.

How similar studies have gone: Previous studies have shown promise in using corticosteroids for pain management in surgical settings, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* American Society of Anesthesiologists status I, II and III, elective, primary, unilateral TKA planned for spinal anesthesia with plain 0.5% bupivacaine.

Exclusion Criteria:

* Refusal of consent
* Pregnancy
* Conditions making the patient unable to fill out questionnaire online, through email or over the phone including with cognitive dysfunction, psychiatric disorder, or non-English speaking patients, or lack of internet access which would prevent post discharge follow-up electronically
* Coagulopathy
* Allergy to or for any other reasons cannot use Acetaminophen, Celebrex, local anesthetic bupivacaine, DEX, MPA or LB
* Patients on any amounts of opioids within one month of the surgery date, any substance abuse such as regular marijuana user (more frequent than once per month)
* Insulin dependent or uncontrolled diabetes defined as, day of surgery finger stick glucose \>200mg/dl, or HbA1C \> 8.0%
* Peripheral Nerve Block site or systemic infection
* Immune compromise (e.g., HIV, chronic glucocorticoid use)
* Severe pre-existing neuropathy
* TKA for indications other than osteoarthritis such as post-traumatic injury or rheumatoid arthritis, history of surgery in the ipsilateral knee joint, revision TKA or bilateral TKA
* Severe hepatic or renal dysfunction (GFR \<50 ml/min)
* Actual body weight \<60 kg
* Patients with active or latent peptic ulcers, diverticulitis, fresh intestinal anastomoses, and non-specific ulcerative colitis

Where it's running

  • Yale New Haven Hospital Saint Raphael Campus
    New Haven, Connecticut, United States
    Recruiting
  • Yale New Haven Hospital York Street Campus
    New Haven, Connecticut, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.